Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Property, Plant & Equipment (Net) (2020 - 2026)

Rallybio (RLYB) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Rallybio 94.61 Mn 94.61 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 20,000.00
Mar 31, 2026 20,000.00
Dec 31, 2025 23,000.00
Dec 31, 2025 23,000.00
Sep 30, 2025 26,000.00
Sep 30, 2025 26,000.00
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 87,000.00
Mar 31, 2025 87,000.00
Dec 31, 2024 115,000.00
Dec 31, 2024 115,000.00
Sep 30, 2024 145,000.00
Sep 30, 2024 145,000.00
Jun 30, 2024 177,000.00
Jun 30, 2024 177,000.00
Mar 31, 2024 211,000.00
Mar 31, 2024 211,000.00
Dec 31, 2023 246,000.00
Dec 31, 2023 246,000.00